{
    "Trade/Device Name(s)": [
        "Contour\u00ae Next EZ Blood Glucose Meter",
        "Contour\u00ae Next EZ Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Bayer Healthcare LLC",
    "510(k) Number": "K130265",
    "Predicate Device Reference 510(k) Number(s)": [
        "K111268"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NBW",
        "LFR"
    ],
    "Summary Letter Date": "May 19, 2014",
    "Summary Letter Received Date": "June 13, 2014",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1345"
    ],
    "Regulation Name(s)": [
        "Glucose Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Whole Blood",
        "Capillary blood",
        "Fresh fingertip capillary whole blood"
    ],
    "Specimen Container(s)": [
        "Test strip"
    ],
    "Instrument(s)/Platform(s)": [
        "Contour\u00ae Next EZ Meter",
        "Contour Plus Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Amperometric detection"
    ],
    "Methodologies": [
        "Electrochemical measurement"
    ],
    "Submission Type(s)": [
        "Meter",
        "System",
        "Test Strip",
        "Control Solution"
    ],
    "Document Summary": "FDA 510(k) summary for Contour\u00ae Next EZ Blood Glucose Meter for self-testing glucose in capillary whole blood using amperometric electrochemical detection.",
    "Indications for Use Summary": "Over-the-counter device for self-testing by persons with diabetes to quantitatively measure glucose in whole blood from fresh fingertip capillary samples, aiding in monitoring diabetes control; not intended for diagnosis or screening or for use on neonates.",
    "fda_folder": "Clinical Chemistry"
}